Rockwell Medical Inc (FRA:RWMA)
€ 1.698 0.002 (0.12%) Market Cap: 52.47 Mil Enterprise Value: 57.65 Mil PE Ratio: 0 PB Ratio: 2.66 GF Score: 49/100

Q3 2020 Rockwell Medical Inc Earnings Call Transcript

Nov 09, 2020 / 09:30PM GMT
Release Date Price: €8.25 (+1.35%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Rockwell Medical 2020 Q3 Results Call. As a reminder, this conference call is being recorded. At this time, I would like to introduce Claudia Styslinger, Investor Relations. Please go ahead.

Claudia Styslinger
Argot Partners, LLC - IR Associate

Welcome to Rockwell Medical's Third Quarter 2020 Earnings Results Call. This is Claudia Styslinger of Argot Partners, the Investor Relations representative for Rockwell Medical. Joining me from Rockwell Medical on today's call are Dr. Russell Ellison, President and Chief Executive Officer; Russell Skibsted, Executive Vice President, Chief Financial Officer and Chief Business Officer; Tim Chole, Vice President of Marketing; and Dr. Marc Hoffman, Chief Medical Officer, who will be joining us for Q&A.

Before we begin, I wanted to note that certain matters we will discuss may constitute forward-looking statements within the meaning of the federal securities laws, including, but not limited to, Rockwell Medical's intention to commercialize Triferic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot